The critical role of BAP1 mutation in the prognosis and treatment selection of kidney renal clear cell carcinoma

BACKGROUND: The BAP1 mutation is commonly found kidney renal clear cell carcinoma (KIRC) and a potential biomarker of individualized therapy. We evaluated the clinical significance of BAP1 mutation in the prognosis and treatment therapies for KIRC. Potential key pathways and related genes associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Guobin, Xuan, Zijun, Li, Zhiqin, Huang, Shuitong, Chen, Guangming, Wu, Yonglu, Chen, Xianxi, Liang, Zhijin, Wu, Aiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475666/
https://www.ncbi.nlm.nih.gov/pubmed/32944533
http://dx.doi.org/10.21037/tau-20-1079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475666/
https://www.ncbi.nlm.nih.gov/pubmed/32944533
http://dx.doi.org/10.21037/tau-20-1079

Ejemplares similares